• 1
    Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children's oncology group. J. Clin. Oncol. 2006; 24: 384451.
  • 2
    Stout AP. Rhabdomyosarcoma of skeletal muscles. Ann. Surg. 1946; 123: 44772.
  • 3
    Paulino AC, Okcu MF. Rhabdomyosarcoma. Curr. Probl. Cancer 2008; 32: 734.
  • 4
    Newton WA Jr, Soule EH, Hamoudi AD et al. Histopathology of childhood sarcomas, intergroup rhabdomyosarcoma studies I and II; clinicopathologic correlation. J. Clin. Oncol. 1988; 6: 6775.
  • 5
    Chui CH, Billups CA, Pappo AS, Rao BN, Spunt SL. Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk – the St Jude Children's Research Hospital experience. J. Pediatr. Surg. 2005; 40: 16915.
  • 6
    Ortega JA, Wharam M, Gehan EA et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the intergroup rhabdomyosarcoma study. J. Clin. Oncol. 1991; 9: 796801.
  • 7
    Donaldson SS, Meza J, Breneman JC et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma: a report from the IRSG. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 71828.